REQUEST A DEMO
Total
USD $0.00
Search more companies

Pharma&Chemical Review Sp. z o.o. (Poland)

Main Activities: All Other Miscellaneous Schools and Instruction
Full name: Pharma&Chemical Review Sp. z o.o. Profile Updated: October 06, 2021
Buy our report for this company USD 19.99 Most recent financial data: 2022 Available in: English & Polish Download a sample report

Pharma&Chemical Review Sp. z o.o. is an enterprise in Poland, with the main office in Warsaw. It operates in the All Other Miscellaneous Schools and Instruction industry. The company was established on July 09, 2019. The latest financial highlights indicate a net sales revenue increase of 153.63% in 2022. There was a total growth of 76.84% in Pharma&Chemical Review Sp. z o.o.’s total assets over the same period. In 2022, Pharma&Chemical Review Sp. z o.o.’s net profit margin decreased by 15.17%.

Headquarters
Ul. Rozlucka 12 15
Warsaw; Mazowieckie; Postal Code: 04-029

Contact Details: Purchase the Pharma&Chemical Review Sp. z o.o. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Pharma&Chemical Review Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Pharma&Chemical Review Sp. z o.o. report to view the information.
Incorporation Date:
July 09, 2019
Key Executives
Purchase this report to view the information.
President
Ownership Details
Purchase this report to view the information.
70%
Purchase this report to view the information.
30%
Company Performance
Financial values in the chart are available after Pharma&Chemical Review Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
153.63%
Total operating revenue
153.67%
Operating profit (EBIT)
-18.25%
Net Profit (Loss) for the Period
-19.7%
Total assets
76.84%
Total equity
79.34%
Operating Profit Margin (ROS)
-16.52%
Net Profit Margin
-15.17%
Return on Equity (ROE)
-54.57%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?